Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Bernhard

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biochemical Pharmacology|October 2, 2012
The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signallingSarah M Bernhard, Kerstin Seidel, Jennifer Schmitz, et al.
Science Advances|March 25, 2026
Mechanistic insights into the therapeutic properties of delta opioid receptorSarah M Bernhard, Susovan Roy Chowdhury, Tsuyoshi Murata, et al.
Nature|May 3, 2023
Ligand and G-protein selectivity in the κ-opioid receptorJianming Han, Jingying Zhang, Antonina L Nazarova, et al.
Research Square|July 29, 2024
Structure-Guided Design of Partial Agonists at an Opioid ReceptorTao Che, Balazs Varga, Sarah M Bernhard, et al.
Nature Communications|March 11, 2023
Molecular mechanism of biased signaling at the kappa opioid receptorAmal El Daibani, Joseph M Paggi, Kuglae Kim, et al.
ACS Central Science|September 2, 2024
Signaling Modulation Mediated by Ligand Water Interactions with the Sodium Site at μORRohini S Ople, Nokomis Ramos-Gonzalez, Qiongyu Li, et al.
Angiogenesis|July 5, 2024
Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibitionFriedrich G Kapp, Farhad Bazgir, Nagi Mahammadzade, et al.
Nature Communications|March 14, 2025
Structure-guided design of partial agonists at an opioid receptorBalazs R Varga, Sarah M Bernhard, Amal El Daibani, et al.
Elife|February 8, 2021
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric siteRajendra Uprety, Tao Che, Saheem A Zaidi, et al.
Journal of Medicinal Chemistry|September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse EffectsSoumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biochemical Pharmacology|October 2, 2012
The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signallingSarah M Bernhard, Kerstin Seidel, Jennifer Schmitz, et al.
Science Advances|March 25, 2026
Mechanistic insights into the therapeutic properties of delta opioid receptorSarah M Bernhard, Susovan Roy Chowdhury, Tsuyoshi Murata, et al.
Nature|May 3, 2023
Ligand and G-protein selectivity in the κ-opioid receptorJianming Han, Jingying Zhang, Antonina L Nazarova, et al.
Research Square|July 29, 2024
Structure-Guided Design of Partial Agonists at an Opioid ReceptorTao Che, Balazs Varga, Sarah M Bernhard, et al.
Nature Communications|March 11, 2023
Molecular mechanism of biased signaling at the kappa opioid receptorAmal El Daibani, Joseph M Paggi, Kuglae Kim, et al.
ACS Central Science|September 2, 2024
Signaling Modulation Mediated by Ligand Water Interactions with the Sodium Site at μORRohini S Ople, Nokomis Ramos-Gonzalez, Qiongyu Li, et al.
Angiogenesis|July 5, 2024
Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibitionFriedrich G Kapp, Farhad Bazgir, Nagi Mahammadzade, et al.
Nature Communications|March 14, 2025
Structure-guided design of partial agonists at an opioid receptorBalazs R Varga, Sarah M Bernhard, Amal El Daibani, et al.
Elife|February 8, 2021
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric siteRajendra Uprety, Tao Che, Saheem A Zaidi, et al.
Journal of Medicinal Chemistry|September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse EffectsSoumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.
Pageof 2